QC
EOLS icon

Quadrature Capital’s Evolus EOLS Stock Holding History

Quadrature Capital’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,068
Closed -$98.9K – 1717
2026
Q1 		$98.9K Buy
24,068
+5,973
+33% +$28.9K ﹤0.01% 1228
2025
Q4 		$120K Buy
18,095
+4,168
+30% +$28.2K ﹤0.01% 1067
2025
Q3 		$85.7K Buy
+13,927
New +$109K ﹤0.01% 896

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Quadrature Capital's EOLS Position: Q2 2026 in Review

Quadrature Capital sold out of Evolus (EOLS) in Q2 2026, closing a stake of 24,068 shares — an estimated $98.9K sold.

Quadrature Capital first reported a position in EOLS in Q3 2025 and held it in 3 quarters. The position peaked at $120K in Q4 2025. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Quadrature Capital reported no remaining Evolus position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 24,068 Evolus shares in Q2 2026, an estimated $98.9K.
  • Quadrature Capital first reported a position in Evolus in Q3 2025 and held it in 3 quarters.
  • Quadrature Capital's Evolus position peaked at $120K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.